Skip to main content
Fig. 3 | BMC Microbiology

Fig. 3

From: Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Fig. 3

Antibacterial activity of bacteriocin-like inhibitory substance (BLIS) extracted from CYLB30 (A) and CYLB47 (B). Six pathogenic bacteria, including Salmonella enterica serovar Choleraesuis, E. coli, K. pneumoniae, P. aeruginosa, E. faecium,and S. aureus, were treated with BLIS. Error bars represent the standard deviation of triplicates. The bacterial viability of pathogens was compared to a negative control without BLIS treatment. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001; ns, no significant difference

Back to article page

BMC Microbiology

ISSN: 1471-2180

Contact us